Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

Author:

Choueiri Toni K.1,Tomczak Piotr1,Park Se Hoon1,Venugopal Balaji1,Ferguson Thomas1,Chang Yen-Hwa1,Hajek Jaroslav1,Symeonides Stefan N.1,Lee Jae Lyun1,Sarwar Naveed1,Thiery-Vuillemin Antoine1,Gross-Goupil Marine1,Mahave Mauricio1,Haas Naomi B.1,Sawrycki Piotr1,Gurney Howard1,Chevreau Christine1,Melichar Bohuslav1,Kopyltsov Evgeniy1,Alva Ajjai1,Burke John M.1,Doshi Gurjyot1,Topart Delphine1,Oudard Stephane1,Hammers Hans1,Kitamura Hiroshi1,Bedke Jens1,Perini Rodolfo F.1,Zhang Pingye1,Imai Kentaro1,Willemann-Rogerio Jaqueline1,Quinn David I.1ORCID,Powles Thomas1

Affiliation:

1. From Dana–Farber Cancer Institute, Boston (T.K.C.); Poznan University of Medical Sciences, Poznan (P.T.), and Wojewódzki Szpital Zespolony im. L. Rydygiera w Toruniu, Torun (P.S.) — both in Poland; Sungkyunkwan University, Samsung Medical Center (S.H.P.), and Asan Medical Center, University of Ulsan College of Medicine (J.L.L.) — both in Seoul, South Korea; Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow (B.V.), Edinburgh Cancer Centre and University of Edinburgh, Edinburgh (S.N...

Funder

Merck Sharp and Dohme

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3